Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Avid Bioservices stock

Own Avid Bioservices stock in just a few minutes.

Avid Bioservices, Inc is a biotechnology business based in the US. Avid Bioservices shares (CDMO) are listed on the NASDAQ and all prices are listed in US Dollars. Avid Bioservices employs 222 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Avid Bioservices

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CDMO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Avid Bioservices share price

Use our graph to track the performance of CDMO stocks over time.

Avid Bioservices shares at a glance

Information last updated 2021-04-30.
52-week range$5.08 - $22.14
50-day moving average $18.89
200-day moving average $14.08
Wall St. target price$22.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.18

Buy Avid Bioservices shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Avid Bioservices stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Avid Bioservices under- or over-valued?

Valuing Avid Bioservices stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avid Bioservices's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Avid Bioservices's EBITDA

Avid Bioservices's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $7.7 million.

The EBITDA is a measure of a Avid Bioservices's overall financial performance and is widely used to measure a its profitability.

Avid Bioservices financials

Revenue TTM $80.8 million
Operating margin TTM 5.36%
Gross profit TTM $3.9 million
Return on assets TTM 1.98%
Return on equity TTM 6.72%
Profit margin 5.51%
Book value $1.40
Market capitalisation $1.3 billion

TTM: trailing 12 months

Shorting Avid Bioservices shares

There are currently 3.7 million Avid Bioservices shares held short by investors – that's known as Avid Bioservices's "short interest". This figure is 2.6% up from 3.6 million last month.

There are a few different ways that this level of interest in shorting Avid Bioservices shares can be evaluated.

Avid Bioservices's "short interest ratio" (SIR)

Avid Bioservices's "short interest ratio" (SIR) is the quantity of Avid Bioservices shares currently shorted divided by the average quantity of Avid Bioservices shares traded daily (recently around 645554.41941075). Avid Bioservices's SIR currently stands at 5.77. In other words for every 100,000 Avid Bioservices shares traded daily on the market, roughly 5770 shares are currently held short.

However Avid Bioservices's short interest can also be evaluated against the total number of Avid Bioservices shares, or, against the total number of tradable Avid Bioservices shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Avid Bioservices's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Avid Bioservices shares in existence, roughly 60 shares are currently held short) or 0.0615% of the tradable shares (for every 100,000 tradable Avid Bioservices shares, roughly 62 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Avid Bioservices.

Find out more about how you can short Avid Bioservices stock.

Avid Bioservices share dividends

We're not expecting Avid Bioservices to pay a dividend over the next 12 months.

Have Avid Bioservices's shares ever split?

Avid Bioservices's shares were split on a 1:7 basis on 9 July 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Avid Bioservices shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Avid Bioservices shares which in turn could have impacted Avid Bioservices's share price.

Avid Bioservices share price volatility

Over the last 12 months, Avid Bioservices's shares have ranged in value from as little as $5.08 up to $22.14. A popular way to gauge a stock's volatility is its "beta".

CDMO.US volatility(beta: 2.23)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avid Bioservices's is 2.23. This would suggest that Avid Bioservices's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Avid Bioservices overview

Avid Bioservices, Inc. , a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site